NO20011253L - Fremgangsmåte for anvendelse av Zot eller zonulin for å inhibering av lymfocyttproliferasjon på en antigenspesifikk måte - Google Patents
Fremgangsmåte for anvendelse av Zot eller zonulin for å inhibering av lymfocyttproliferasjon på en antigenspesifikk måteInfo
- Publication number
- NO20011253L NO20011253L NO20011253A NO20011253A NO20011253L NO 20011253 L NO20011253 L NO 20011253L NO 20011253 A NO20011253 A NO 20011253A NO 20011253 A NO20011253 A NO 20011253A NO 20011253 L NO20011253 L NO 20011253L
- Authority
- NO
- Norway
- Prior art keywords
- zot
- zonulin
- lymphocyte proliferation
- antigen
- antigen specific
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10026698P | 1998-09-14 | 1998-09-14 | |
| PCT/US1999/018842 WO2000015252A1 (en) | 1998-09-14 | 1999-09-09 | Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011253D0 NO20011253D0 (no) | 2001-03-13 |
| NO20011253L true NO20011253L (no) | 2001-03-15 |
Family
ID=22278888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011253A NO20011253L (no) | 1998-09-14 | 2001-03-13 | Fremgangsmåte for anvendelse av Zot eller zonulin for å inhibering av lymfocyttproliferasjon på en antigenspesifikk måte |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1113813B1 (es) |
| JP (1) | JP2002524531A (es) |
| KR (1) | KR100615442B1 (es) |
| CN (1) | CN1228084C (es) |
| AT (1) | ATE296110T1 (es) |
| AU (1) | AU754142B2 (es) |
| CA (1) | CA2342771A1 (es) |
| DE (1) | DE69925496T2 (es) |
| ES (1) | ES2239480T3 (es) |
| HU (1) | HUP0103965A3 (es) |
| IL (2) | IL141563A0 (es) |
| MX (1) | MXPA01002600A (es) |
| NO (1) | NO20011253L (es) |
| NZ (2) | NZ510150A (es) |
| RU (1) | RU2214271C2 (es) |
| WO (1) | WO2000015252A1 (es) |
| ZA (1) | ZA200102071B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458925B1 (en) * | 1998-08-03 | 2002-10-01 | University Of Maryland, Baltimore | Peptide antagonists of zonulin and methods for use of the same |
| EP2062909A1 (en) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Peptide production and purification process |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945510A (en) * | 1997-05-21 | 1999-08-31 | University Of Maryland, Baltimore | Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
-
1999
- 1999-09-09 CA CA002342771A patent/CA2342771A1/en not_active Abandoned
- 1999-09-09 RU RU2001110101/14A patent/RU2214271C2/ru not_active IP Right Cessation
- 1999-09-09 AT AT99969032T patent/ATE296110T1/de not_active IP Right Cessation
- 1999-09-09 AU AU60190/99A patent/AU754142B2/en not_active Ceased
- 1999-09-09 CN CNB998108650A patent/CN1228084C/zh not_active Expired - Fee Related
- 1999-09-09 HU HU0103965A patent/HUP0103965A3/hu unknown
- 1999-09-09 WO PCT/US1999/018842 patent/WO2000015252A1/en active IP Right Grant
- 1999-09-09 DE DE69925496T patent/DE69925496T2/de not_active Expired - Fee Related
- 1999-09-09 NZ NZ510150A patent/NZ510150A/xx unknown
- 1999-09-09 IL IL14156399A patent/IL141563A0/xx active IP Right Grant
- 1999-09-09 JP JP2000569836A patent/JP2002524531A/ja active Pending
- 1999-09-09 ES ES99969032T patent/ES2239480T3/es not_active Expired - Lifetime
- 1999-09-09 EP EP99969032A patent/EP1113813B1/en not_active Expired - Lifetime
- 1999-09-09 KR KR1020017003317A patent/KR100615442B1/ko not_active IP Right Cessation
- 1999-09-09 MX MXPA01002600A patent/MXPA01002600A/es not_active IP Right Cessation
-
2001
- 2001-02-21 IL IL141563A patent/IL141563A/en not_active IP Right Cessation
- 2001-03-13 ZA ZA200102071A patent/ZA200102071B/en unknown
- 2001-03-13 NO NO20011253A patent/NO20011253L/no not_active Application Discontinuation
-
2002
- 2002-09-16 NZ NZ521410A patent/NZ521410A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69925496D1 (de) | 2005-06-30 |
| NZ521410A (en) | 2005-06-24 |
| ATE296110T1 (de) | 2005-06-15 |
| CN1317975A (zh) | 2001-10-17 |
| EP1113813A1 (en) | 2001-07-11 |
| ZA200102071B (en) | 2002-02-25 |
| AU6019099A (en) | 2000-04-03 |
| EP1113813A4 (en) | 2002-05-29 |
| NZ510150A (en) | 2002-10-25 |
| AU754142B2 (en) | 2002-11-07 |
| IL141563A0 (en) | 2002-03-10 |
| RU2214271C2 (ru) | 2003-10-20 |
| CN1228084C (zh) | 2005-11-23 |
| DE69925496T2 (de) | 2006-02-02 |
| KR100615442B1 (ko) | 2006-08-25 |
| ES2239480T3 (es) | 2005-09-16 |
| MXPA01002600A (es) | 2002-04-08 |
| IL141563A (en) | 2006-06-11 |
| HUP0103965A3 (en) | 2004-06-28 |
| NO20011253D0 (no) | 2001-03-13 |
| JP2002524531A (ja) | 2002-08-06 |
| KR20010075114A (ko) | 2001-08-09 |
| EP1113813B1 (en) | 2005-05-25 |
| CA2342771A1 (en) | 2000-03-23 |
| HUP0103965A2 (hu) | 2002-03-28 |
| WO2000015252A1 (en) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0865293T3 (da) | Blokering af T-lymfocyt ned-regulering associeret med CTLA-4-signalering | |
| DK0975359T3 (da) | Anvendelse af forbindelser, der binder en cytoplasmisk dipeptidase til synergistisk virkning af immunreaktionen | |
| DK0631502T3 (da) | Lymfocytaktivitetsregulering ved hjælp af HLA-peptider | |
| DK0991403T3 (da) | Anvendelse af mikropartikler med adsorberet antigen til stimulering af immunresponser | |
| DK0985675T3 (da) | Hydrosilaniseringsfremgangsmåde med höjt udbytte | |
| EP0863913A4 (en) | METHOD FOR RECOVERING THE DENSITY OF ANTIGENS ON ANTIGENT PRESENTING CELLS | |
| BR9809656A (pt) | Composição imunopotencializante | |
| DK1003552T3 (da) | LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation | |
| NO20011253L (no) | Fremgangsmåte for anvendelse av Zot eller zonulin for å inhibering av lymfocyttproliferasjon på en antigenspesifikk måte | |
| Iwasaki et al. | Prostaglandin E2 downregulates interleukin‐12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon‐γ | |
| DE69637078D1 (de) | Polypeptid-fragmente die fähig sind mit dem antigen i/ii von streptococcus mutans zu konkurrieren | |
| Sharp et al. | Expression of delta opioid receptors and transcripts by splenic T cells | |
| ATE334193T1 (de) | Verfahren zur reduzierung von spezifischen immunreaktionen | |
| DE69432472D1 (de) | Verfahren zur hemmung der phagozytose | |
| Sandi et al. | Effects of HPA hormones on adapted lymphocyte responsiveness to repeated stress | |
| Ozegbe et al. | Impact of cAMP on the T‐cell response to type II collagen | |
| ES2185024T3 (es) | Procedimiento que permite mejorar el rendimiento de un reactivo inmunologico en un dosificado inmunologico. | |
| Hildebrandt et al. | Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress‐induced, cytokine‐mediated murine abortions | |
| ATE210989T1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
| DE69938827D1 (de) | Verwendung von inhibitoren von asparaginyl-endopeptidase aus säugetieren zur modulierung des immunsystemen | |
| BR9713959A (pt) | Uso de material antigênico e/ou imunorregulatório derivado da mycobacterium vaccae, composição compreedendo o mesmo, e, processo para regulação descendente da atividade th2 do sistema imunológico de um indivìduo | |
| DK1218028T3 (da) | Dendritiske celler som bliver aktiveret i tilstedeværelsen glucocorticoidhormoner er i stand til at undertrykke antigenspecifikt T-cellerespons | |
| MX9300294A (es) | Metodo para inhibir al menos una porcion de una respuesta del anticuerpo especifico del antigeno mediante el sistema inmune de un mamifero | |
| NO962943D0 (no) | Peptider og fremgangsmåte mot psoriasis | |
| HK1021318A1 (en) | Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |